Startup Dossier
Ciloa
A Montpellier-based biotech pioneer in bioengineering small extracellular vesicles (exosomes) to deliver therapeutic proteins, specifically using its proprietary EVENGI platform to create a stable, functional adiponectin-loaded exosome called APN‑sEV for treating metabolic diseases.
active
Typestartup
SectorBioTech
LocationMontpellier
About
A Montpellier-based biotech pioneer in bioengineering small extracellular vesicles (exosomes) to deliver therapeutic proteins, specifically using its proprietary EVENGI platform to create a stable, functional adiponectin-loaded exosome called APN‑sEV for treating metabolic diseases.
Structural DNA
Legal Name
Ciloa
SIREN
531963692
Founders & Team
Funding Lineage
Grant
France 2030 (Lead)
€6.5M
Jul 2025
Seed
0 investors
€5.0M
Mar 2022